Danaher logo

Danaher Share Price Today

(NASDAQ: DHR)

Danaher share price is $205.85 & ₹17,590.09 as on 29 Mar 2025, 2.30 'hrs' IST

$205.85

-4.26

(-2.03%)

Market is closed - opens 7 PM, 31 Mar 2025

View live Danaher share price in Dollar and Rupees. Guide to invest in Danaher stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Danaher, along with analyst recommendations, forecasts, and comprehensive financials.

Danaher share price movements

  • Today's Low: $205.44
    Today's High: $210.14

    Day's Volatility :2.23%

  • 52 Weeks Low: $196.80
    52 Weeks High: $281.70

    52 Weeks Volatility :30.14%

Danaher (DHR) Returns

PeriodDanaher Corp.Sector (Health Care)S&P500
3 Months
-10.36%
4.0%
-6.5%
6 Months
-25.96%
-5.6%
-2.7%
1 Year
-16.93%
-2.2%
6.2%
3 Years
-29.82%
4.7%
20.5%

Danaher (DHR) Key Statistics

in dollars & INR

Previous Close
$210.11
Open
$210.07
Today's High
$210.135
Today's Low
$205.44
Market Capitalization
$147.3B
Today's Volume
$2.4M
52 Week High
$281.7
52 Week Low
$196.8
Revenue TTM
$23.9B
EBITDA
$7.5B
Earnings Per Share (EPS)
$5.29
PE Ratio
38.91
Dividend Yield
0.62%
Profit Margin
16.33%
Quarterly Earnings Growth YOY
0.04%
Return On Equity TTM
7.57%

How to invest in Danaher Stock (DHR) from India?

It is very easy for Indian residents to invest directly in Danaher from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Danaher stock in both Indian Rupees (INR) and US Dollars (USD). Search for Danaher or DHR on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Danaher or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Danaher shares which would translate to 0.004 fractional shares of Danaher as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Danaher, in just a few clicks!

Returns in Danaher (DHR) for Indian investors in Rupees

The Danaher stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Danaher investment value today

Current value as on today

₹85,612

Returns

₹14,388

(-14.39%)

Returns from Danaher Stock

₹16,926 (-16.93%)

Dollar Returns

₹2,538 (+2.54%)

Indian investors sentiment towards Danaher (DHR)

-58.74%

Period: Feb 27, 2025 to Mar 29, 2025. Change in 30 Days versus previous period

Investment in Danaher Shares from India has dropped by -58.74% over the past 30 days, indicating reduced transactional activity.

-29%

Period: Feb 27, 2025 to Mar 29, 2025. Change in 30 Days versus previous period

Search interest for Danaher Stock from India on INDmoney has decreased by -29% in the last 30 days, reflecting a downward trend in search activity.

Indian Mutual Funds that invest in Danaher Stock (DHR Ticker)

Global Institutional Holdings in Danaher

  • Vanguard Group Inc

    8.36%

  • BlackRock Inc

    7.03%

  • State Street Corp

    3.83%

  • Wellington Management Company LLP

    2.98%

  • FMR Inc

    2.87%

  • T. Rowe Price Associates, Inc.

    2.66%

Analyst Recommendation on Danaher

Buy

    73%Buy

    23%Hold

    3%Sell

Based on 30 Wall street analysts offering stock ratings for Danaher(by analysts ranked 0 to 5 stars)

Based on 30 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
22
21
22
Hold
7
8
7
Sell
1
1
1

Analyst Forecast on Danaher Stock (DHR)

What analysts predicted

Upside of 29.33%

Target:

$266.23

Current:

$205.85

Insights on Danaher Stock (Ticker Symbol: DHR)

  • Price Movement

    In the last 1 month, DHR stock has moved down by -0.9%
  • Increasing Revenue

    Danaher Corp. has shown consistent growth in revenue over the last three quarters. The revenue increased from $5.74 billion to $6.53 billion, with an average increase of 6.1% each quarter.
  • Increasing Net Profit

    Danaher Corp. has shown positive profit trends over the last two quarters. The net profit increased from $818 million in the previous quarter to $1.08 billion in the most recent quarter. This represents an average increase of 24.7% per quarter.
  • DHR vs TMO (1 yr)

    In the last 1 year, Danaher Corp. has experienced a drawdown of -17.6%, however Thermo Fisher Scientific, Inc. resisted the overall trend and outperformed by 3.7%
  • DHR vs TMO (3 yr)

    In the last 3 years, Danaher Corp. has experienced a drawdown of -30.4%, however Thermo Fisher Scientific, Inc. resisted the overall trend and outperformed by 14.8%
  • Price to Sales

    Danaher Corp. is currently being valued by investors at a Price-to-Sales Ratio of 6.3, meaning investors are willing to pay $6.3 for every $1 of sales the company generates. In comparison, Thermo Fisher Scientific, Inc. has a lower valuation, with investors paying $4.5 for every $1 of sales. This indicates that Danaher Corp. is perceived as having higher growth potential or a stronger market position compared to Thermo Fisher.

DHR Danaher Financials in INR & Dollars

FY19Y/Y Change
Revenue
$17.9B
↓ 9.96%
Net Income
$3.0B
↑ 13.48%
Net Profit Margin
16.8%
↑ 3.47%
FY20Y/Y Change
Revenue
$22.3B
↑ 24.41%
Net Income
$3.6B
↑ 21.2%
Net Profit Margin
16.36%
↓ 0.44%
FY21Y/Y Change
Revenue
$29.5B
↑ 32.17%
Net Income
$6.4B
↑ 76.44%
Net Profit Margin
21.84%
↑ 5.48%
FY22Y/Y Change
Revenue
$31.5B
↑ 6.85%
Net Income
$7.2B
↑ 12.06%
Net Profit Margin
22.91%
↑ 1.07%
FY23Y/Y Change
Revenue
$23.9B
↓ 24.09%
Net Income
$4.7B
↓ 34.21%
Net Profit Margin
19.85%
↓ 3.06%
FY24Y/Y Change
Revenue
$23.9B
↓ 0.06%
Net Income
$3.9B
↓ 17.79%
Net Profit Margin
16.33%
↓ 3.52%
Q3 FY23Q/Q Change
Revenue
$6.9B
↓ 3.97%
Net Income
$1.1B
↑ 2.08%
Net Profit Margin
16.43%
↑ 0.98%
Q4 FY23Q/Q Change
Revenue
$2.7B
↓ 60.82%
Net Income
$1.1B
↓ 4.43%
Net Profit Margin
40.07%
↑ 23.64%
Q1 FY24Q/Q Change
Revenue
$5.8B
↑ 115.22%
Net Income
$1.1B
↑ 0.83%
Net Profit Margin
18.77%
↓ 21.3%
Q2 FY24Q/Q Change
Revenue
$5.7B
↓ 0.91%
Net Income
$907.0M
↓ 16.64%
Net Profit Margin
15.79%
↓ 2.98%
Q3 FY24Q/Q Change
Revenue
$5.8B
↑ 0.96%
Net Income
$818.0M
↓ 9.81%
Net Profit Margin
14.11%
↓ 1.68%
Q4 FY24Q/Q Change
Revenue
$6.5B
↑ 12.76%
Net Income
$1.1B
↑ 32.76%
Net Profit Margin
16.61%
↑ 2.5%
FY19Y/Y Change
Profit
$10.0B
↓ 10.11%
FY20Y/Y Change
Profit
$12.5B
↑ 24.95%
FY21Y/Y Change
Profit
$18.0B
↑ 43.9%
FY22Y/Y Change
Profit
$18.9B
↑ 5.55%
FY23Y/Y Change
Profit
$14.0B
↓ 25.94%
FY24Y/Y Change
Profit
$14.2B
↑ 1.23%
Q3 FY23Q/Q Change
Profit
$4.0B
↓ 1.01%
Q4 FY23Q/Q Change
Profit
$1.6B
↓ 59.42%
Q1 FY24Q/Q Change
Profit
$3.5B
↑ 114.85%
Q2 FY24Q/Q Change
Profit
$3.4B
↓ 1.69%
Q3 FY24Q/Q Change
Profit
$3.4B
↓ 0.79%
Q4 FY24Q/Q Change
Profit
$3.9B
↑ 14.38%
FY19Y/Y Change
Operating Cash Flow
$4.0B
↓ 1.75%
Investing Cash Flow
$-1.2B
↓ 58.02%
Financing Cash Flow
$16.4B
↓ 2153.44%
FY20Y/Y Change
Operating Cash Flow
$6.2B
↑ 57.1%
Investing Cash Flow
$-21.2B
↑ 1615.45%
Financing Cash Flow
$1.0B
↓ 93.85%
FY21Y/Y Change
Operating Cash Flow
$8.4B
↑ 34.63%
Investing Cash Flow
$-13.0B
↓ 38.85%
Financing Cash Flow
$1.3B
↑ 28.73%
FY22Y/Y Change
Operating Cash Flow
$8.5B
↑ 1.93%
Investing Cash Flow
$-2.2B
↓ 82.8%
Financing Cash Flow
$-2.6B
↓ 298.46%
Q3 FY23Q/Q Change
Operating Cash Flow
$1.7B
↓ 13.19%
Investing Cash Flow
$-1.1B
↑ 146.87%
Financing Cash Flow
$2.4B
↓ 1274.52%

Danaher Technicals Summary

Sell

Neutral

Buy

Danaher is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.

Danaher (DHR) Vs Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Danaher Corp. logo
-0.92%
-25.96%
-16.93%
-29.82%
48.72%
Agilent Technologies Inc. logo
-8.78%
-21.41%
-19.83%
-11.82%
62.93%
Idexx Laboratories, Inc. logo
-4.86%
-17.69%
-21.89%
-23.98%
71.68%
Thermo Fisher Scientific, Inc. logo
-5.44%
-19.14%
-13.38%
-15.32%
76.36%
Iqvia Holdings Inc. logo
-6.04%
-25.14%
-28.72%
-23.28%
64.46%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Danaher Corp. logo
38.91
38.91
2.05
7.66
0.08
0.04
0.01
68.9
Agilent Technologies Inc. logo
26.83
26.83
1.94
5.57
0.21
0.08
0.01
21.13
Idexx Laboratories, Inc. logo
38.9
38.9
3.59
11.97
0.58
0.23
NA
19.55
Thermo Fisher Scientific, Inc. logo
30.29
30.29
1.89
23.36
0.13
0.05
0.0
130.22
Iqvia Holdings Inc. logo
23.65
23.65
0.96
11.87
0.23
0.05
NA
34.45
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Danaher Corp. logo
Buy
$147.3B
48.72%
38.91
16.33%
Agilent Technologies Inc. logo
Buy
$33.3B
62.93%
26.83
19.27%
Idexx Laboratories, Inc. logo
Buy
$33.8B
71.68%
38.9
22.78%
Thermo Fisher Scientific, Inc. logo
Buy
$188.7B
76.36%
30.29
14.77%
Iqvia Holdings Inc. logo
Buy
$31.3B
64.46%
23.65
8.91%

Danaher Dividend announcements

  • Danaher Dividends March, 2025

    In the quarter ending March,2025. Danaher has declared dividend of $0.32

About Danaher

Danaher Corporation designs, manufactures, and markets professional, medical, research, and industrial products and services in the United States, China, and internationally. It operates through Biotechnology, Life Sciences, and Diagnostics segments. The Biotechnology segment offers bioprocessing technologies, consumables, services, and solutions that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, and aseptic fill finish; single-use hardware, consumables, and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services for diagnostic and assay development; and healthcare filtration solutions. Its Life Sciences segment provides mass spectrometers; bioanalytical measurement systems; flow cytometry, genomics, lab automation, centrifugation, liquid handling automation instruments, antibodies, and particle counting and characterization; genome sample preparation; microscopes; protein consumables; filtration products; and genomic medicines, such as custom nucleic acid products, and plasmid DNA, RNA, and proteins under the ABCAM, ALDEVRON, BECKMAN COULTER, GENEDATA, IDT, LEICA MICROSYSTEMS, MOLECULAR DEVICES, PALL, PHENOMENEX, and SCIEX brands. The Diagnostics segment offers clinical instruments, consumables, software, and services in the areas of clinical chemistry, immunoassay, hematology, and microbiology for hospitals, physicians' offices, reference laboratories, and other critical care settings. The company was formerly known as Diversified Mortgage Investors, Inc. and changed its name to Danaher Corporation in 1984. Danaher Corporation was founded in 1969 and is headquartered in Washington, the District Of Columbia.
Organization
Danaher
Employees
61000
CEO
Mr. Rainer M. Blair
Industry
Instruments and Related Products Manufacturing for Measuring, Displaying, and Controlling Industrial Process Variables

Management People of Danaher

NameTitle
Mr. Steven M. Rales
Co-Founder & Chairman
Mr. Rainer M. Blair
President, CEO & Director
Ms. Georgeann F. Couchara
Senior Vice President of Human Resources
Mr. Daniel A. Raskas J.D.
Senior Vice President of Corporate Development
Mr. Frank T. McFaden
Vice President and Treasurer

Important FAQs about investing in DHR Stock from India :

What is Danaher share price today?

Danaher share price today stands at $205.85, Open: $210.07 ; Previous Close: $210.11 ; High: $210.14 ; Low: $205.44 ; 52 Week High: $281.70 ; 52 Week Low: $196.80.

The stock opens at $210.07, after a previous close of $210.11. The stock reached a daily high of $210.14 and a low of $205.44, with a 52-week high of $281.70 and a 52-week low of $196.80.

Can Indians buy Danaher shares?

Yes, Indians can invest in the Danaher (DHR) from India.

With INDmoney, you can buy Danaher at 0 brokerage. The step-by-step process is as follows:

  • Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
  • Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
  • Once funds are transferred successfully, you can buy Danaher at zero transaction cost.

How can I buy Danaher shares from India?

It is very easy to buy Danaher from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Danaher (DHR) be purchased?

Yes, you can buy fractional shares of Danaher with INDmoney app.

What are the documents required to start investing in Danaher stocks?

To start investing in Danaher, You will need the following documents:

  • Proof of Identification (PAN, Aadhaar etc)
  • Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

What are today’s High and Low prices of Danaher Stock (DHR)?

Today’s highest price of Danaher (DHR) is $210.14.

Today’s lowest price of Danaher (DHR) is $205.44.

What is today's market capitalisation of Danaher?

Today's market capitalisation of Danaher DHR is 147.3B

What is the 52 Week High and Low Range of Danaher Stock (DHR)?

  • 52 Week High

    $281.70

  • 52 Week Low

    $196.80

What are the historical returns of Danaher (DHR)?

  • 1 Month Returns

    -0.92%

  • 3 Months Returns

    -25.96%

  • 1 Year Returns

    -16.93%

  • 5 Years Returns

    48.72%

Who is the Chief Executive Officer (CEO) of Danaher ?

Mr. Rainer M. Blair is the current Chief Executive Officer (CEO) of Danaher.

Discover More